Yang, Y., He, Y., Fan, Z., Chen, X., Liu, Y., Zhang, C., . . . Ouyang, T. (2023). Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial. Nature Portfolio.
Chicago Style (17th ed.) CitationYang, Yang, et al. Author Correction: Phase III Study of HR-positive/HER2-negative/lymph Node-positive Breast Cancer Non-responsive to Primary Chemotherapy: A Randomized Trial. Nature Portfolio, 2023.
MLA (9th ed.) CitationYang, Yang, et al. Author Correction: Phase III Study of HR-positive/HER2-negative/lymph Node-positive Breast Cancer Non-responsive to Primary Chemotherapy: A Randomized Trial. Nature Portfolio, 2023.
Warning: These citations may not always be 100% accurate.